At Close: 4:00 PM
Pre Market: 5:11 AM
ChromaDex Stock Price Graph
ChromaDex Stock Price Today
ChromaDex Corporation (CDXC) stock declined over -6.31% intraday to trade at $1.41 a share on NASDAQ. The stock opened with a loss of -1.00% at $1.49 and touched an intraday high of $1.50, falling -6.31% against the last close of $1.50. The ChromaDex Corporation in stock market went to a low of $1.48 during the session.
ChromaDex Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
ChromaDex Stock Price History Chart
10900 Wilshire BoulevardLos Angeles, CA 90024US
Contact #:310 388 6706
Sales or Revenue$77.35 Million
5Y Sales Change27.70%
Fiscal Year EndsDec. 2022
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Frequently Asked Questions
What is the current ChromaDex Corporation (CDXC) stock price?
ChromaDex Corporation (NASDAQ: CDXC) stock price is $1.41 in the last trading session. During the trading session, CDXC stock reached the peak price of $1.50 while $1.48 was the lowest point it dropped to. The percentage change in CDXC stock occurred in the recent session was -6.31% while the dollar amount for the price change in CDXC stock was -$0.09.
CDXC's industry and sector of operation?
The NASDAQ listed CDXC is part of Biotechnology industry that operates in the broader Healthcare sector. ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services.
Who are the executives of CDXC?
Dr. Andrew Shao Ph.D.
Senior Vice President of Global Regulatory & Scientific Affairs
Senior Vice President of People Matters
Mr. Robert N. Fried
Chief Executive Officer & Director
Vice President of Global Marketing & Communications
How CDXC did perform over past 52-week?
CDXC's closing price is 0.17% higher than its 52-week low of $1.15 where as its distance from 52-week high of $2.37 is -0.43%.
How many employees does CDXC have?
Number of CDXC employees currently stands at 113.00. CDXC operates from 10900 Wilshire Boulevard</br>Los Angeles, CA 90024</br>US.
Link for CDXC official website?
Official Website of CDXC is: https://www.chromadex.com
How do I contact CDXC?
CDXC could be contacted at phone #310 388 6706 and can also be accessed through its website. CDXC operates from 10900 Wilshire Boulevard</br>Los Angeles, CA 90024</br>US.
How many shares of CDXC are traded daily?
CDXC stock volume for the day was 65617.00 shares. The average number of CDXC shares traded daily for last 3 months was 139.77 Thousands.
What is the market cap of CDXC currently?
The market value of CDXC currently stands at $120.11 Million with its latest stock price at $1.41 and 74.8 Million of its shares outstanding.